Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 5/2018

01-10-2018

Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas

Authors: Pragati Advani, Melissa Bondy, Patricia A. Thompson, María Elena Martínez, Jesse N. Nodora, Sally W. Vernon, Pamela Diamond, Jason Burnett, Abenaa M. Brewster

Published in: Journal of Cancer Survivorship | Issue 5/2018

Login to get access

Abstract

Purpose

Given the increasing number and diversity of cancer survivors in the USA and persistent racial/ethnic disparities in breast cancer care, we sought to examine the role of acculturation in adherence to recommended surgical treatment and survivorship care recommendations.

Methods

Study participants included 343 Mexican American women with stage I to III breast cancer who participated in the Ella Binational Breast Cancer Study and were treated at The University of Texas MD Anderson Cancer Center in Houston, Texas, between March 2007 and June 2011. Participants completed a questionnaire measuring acculturation, and clinical and demographic variables were obtained from an institutional database. Multivariable logistic regression models were constructed to examine differences in surgical procedures received and adherence to long-term survivorship care by acculturation level.

Results

Bilingual (odds ratio [OR] = 1.85; 95% confidence interval [CI] = 0.85–4.02, P = .11) and English-dominant women (OR = 2.39; 95% CI = 1.02–5.61, P = .04) were more likely to receive breast-conserving surgery (versus mastectomy) than were Spanish-dominant women. Among all patients, adherence to surveillance mammography and clinic visits decreased over time; the decline in clinic visit adherence was statistically significant (P = .005). Although no statistically significant association was found between acculturation and adherence to long-term survivorship care, receipt of breast-conserving surgery (versus mastectomy) was significantly associated with higher adherence to surveillance mammograms.

Conclusion

Acculturation may play a role in decision-making about surgical management of breast cancer, and further studies with larger samples are needed to explore its role in adherence to survivorship care recommendations. Findings from this study may help identify patients requiring additional support while making decisions pertaining to their cancer treatment and survivorship care.
Literature
1.
Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457–80.CrossRefPubMed
2.
Profile America: Facts for features - Hispanic heritage, U.C. Bureau, Editor. 2016: Washington DC.
3.
Martínez ME, Gutiérrez-Millan LE, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Anduro-Corona I, et al. Comparative study of breast cancer in Mexican and Mexican-American women. Health. 2010;2(09):1040–8.CrossRef
4.
Grant SR, Walker GV, Guadagnolo BA, Koshy M, Allen PK, Mahmood U. Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer. Cancer. 2015;121(12):2020–8.CrossRefPubMedPubMedCentral
5.
Martinez-Tyson D, Barnett Pathak E, Soler-Vila H, Flores AM. Looking under the hispanic umbrella: Cancer mortality among Cubans, Mexicans, Puerto Ricans and other hispanics in Florida. J Immigr Minor Health. 2009;11(4):249–57.CrossRefPubMed
6.
Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, et al. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomark Prev. 2009;18(8):2162–9.CrossRef
7.
Group, E.B.C.T.C. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.CrossRef
8.
Advani PS, et al. Ethnic disparities in adherence to breast cancer survivorship surveillance care. Cancer. 2013.
9.
Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5.CrossRefPubMed
10.
Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.CrossRefPubMed
11.
Szapocznik J, Scopetta MA, King OE. Theory and practice in matching treatment to the special characteristics and problems of Cuban immigrants. J Community Psychol. 1978;6(2):112–22.CrossRefPubMed
12.
Rogler LH, Cortes DE, Malgady RG. Acculturation and mental health status among Hispanics: convergence and new directions for research. Am Psychol. 1991;46(6):585–97.CrossRefPubMed
13.
Abraído-Lanza AF, Armbrister AN, Flórez KR, Aguirre AN. Toward a theory-driven model of acculturation in public health research. Am J Public Health. 2006;96(8):1342–6.CrossRefPubMedPubMedCentral
14.
15.
Network, N.C.C., NCCN Clinical Practice Guidelines in Oncology, Breast Cancer. 2013, National Comprehensive Cancer Network.
16.
Nold RJ, Beamer RL, Helmer SD, McBoyle MF. Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy. Am J Surg. 2000;180(6):413–8.CrossRefPubMed
17.
van Dongen JA, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143–50.CrossRef
18.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.CrossRef
19.
Al-Ghazal S, Fallowfield L, Blamey R. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer. 2000;36(15):1938–43.CrossRef
20.
Deng H, et al. Breast-conserving surgery versus modified radical mastectomy for early breast cancer: clinical efficacy and quality of life [J]. Chinese Journal of General Surgery. 2012;9:018.
21.
Kummerow KL, du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surgery. 2015;150(1):9–16.CrossRefPubMed
22.
Hawley ST, Griggs JJ, Hamilton AS, Graff JJ, Janz NK, Morrow M, et al. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst. 2009;101(19):1337–47.CrossRefPubMedPubMedCentral
23.
Collins ED, Moore CP, Clay KF, Kearing SA, O'Connor AM, Llewellyn-Thomas HA, et al. Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol. 2008;27(4):519–25.CrossRefPubMed
24.
Kotwall CA, Maxwell JG, Covington DL, Churchill P, Smith SE, Covan EK. Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment. Ann Surg Oncol. 1996;3(2):169–75.CrossRefPubMed
25.
Molenaar S, Oort F, Sprangers M, Rutgers E, Luiten E, Mulder J, et al. Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer. 2004;90(11):2123–30.CrossRefPubMedPubMedCentral
26.
Fisher CS, Martin-Dunlap T, Ruppel MB, Gao F, Atkins J, Margenthaler JA. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Ann Surg Oncol. 2012;19(10):3246–50.CrossRefPubMed
27.
Stafford D, Szczys R, Becker R, Anderson J, Bushfield S. How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1998;176(6):515–9.CrossRefPubMed
28.
Grunfeld E, Noorani H, McGahan L, Paszat L, Coyle D, van Walraven C, et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast. 2002;11(3):228–35.CrossRefPubMed
29.
Nodora JN, et al. Reproductive and hormonal risk profile according to language acculturation and country of residence in the ella binational breast cancer study. J Women’s Health. 2014.
30.
Garcia RZ, Carvajal SC, Wilkinson AV, Thompson PA, Nodora JN, Komenaka IK, et al. Factors that influence mammography use and breast cancer detection among Mexican-American and African-American women. Cancer Causes Control. 2012;23(1):165–73.CrossRefPubMed
31.
Greene FL, et al. AJCC cancer staging handbook: TNM classification of malignant tumors. 2002: Springer Science & Business Media.
32.
Marín G, Gamba RJ. A new measurement of acculturation for Hispanics: the Bidimensional acculturation scale for Hispanics (BAS). Hisp J Behav Sci. 1996;18(3):297–316.CrossRef
33.
Hamilton AS, Hofer TP, Hawley ST, Morrell D, Leventhal M, Deapen D, et al. Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment. Cancer Epidemiol Biomark Prev. 2009;18(7):2022–9.CrossRef
34.
35.
Thomson MD, Hoffman-Goetz L. Defining and measuring acculturation: a systematic review of public health studies with Hispanic populations in the United States. Soc Sci Med. 2009;69(7):983–91.CrossRefPubMed
36.
Balcazar H, Castro FG, Krull JL. Cancer risk reduction in Mexican American women: the role of acculturation, education, and health risk factors. Health Educ Behav. 1995;22(1):61–84.
37.
Akinyemiju T, Sakhuja S, Vin-Raviv N. Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status. Cancer Epidemiol. 2016;43:63–9.CrossRefPubMedPubMedCentral
38.
Esnaola NF, Knott K, Finney C, Gebregziabher M, Ford ME. Urban/rural residence moderates effect of race on receipt of surgery in patients with nonmetastatic breast cancer: a report from the South Carolina central cancer registry. Ann Surg Oncol. 2008;15(7):1828–36.CrossRefPubMedPubMedCentral
39.
Gomez SL, France A-M, Lee MM. Socioeconomic status, immigration/acculturation, and ethnic variations in breast conserving surgery, San Francisco Bay area. Ethn Dis. 2004;14(1):134–40.PubMed
40.
Kaplan CP, Nápoles AM, Hwang ES, Bloom J, Stewart S, Nickleach D, et al. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Women's Health. 2011;20(2):215–23.CrossRef
41.
Lim J-W, Gonzalez P, Wang-Letzkus MF, Ashing-Giwa KT. Understanding the cultural health belief model influencing health behaviors and health-related quality of life between Latina and Asian-American breast cancer survivors. Support Care Cancer. 2009;17(9):1137–47.CrossRefPubMed
42.
Morris CR, Cohen R, Schlag R, Wright WE. Increasing trends in the use of breast-conserving surgery in California. Am J Public Health. 2000;90(2):281–4.CrossRefPubMedPubMedCentral
43.
Gilligan MA, et al. Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care. 2002;40(3):181–9.CrossRefPubMed
44.
Polednak AP. Trends in, and predictors of, breast-conserving surgery and radiotherapy for breast cancer in Connecticut, 1988–1997. Int J Radiat Oncol Biol Phys. 2002;53(1):157–63.CrossRefPubMed
45.
Gomez SL, Lichtensztajn D, Kurian AW, Telli ML, Chang ET, Keegan THM, et al. Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. J Clin Oncol. 2010;28(10):e155–7.CrossRefPubMedPubMedCentral
46.
Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst. 2001;93(6):447–55.CrossRefPubMed
47.
Liu J-J, Zhang S, Hao X, Xie J, Zhao J, Wang J, et al. Breast-conserving therapy versus modified radical mastectomy: socioeconomic status determines who receives what—results from case-control study in Tianjin, China. Cancer Epidemiol. 2012;36(1):89–93.CrossRefPubMed
48.
Hadley J, Mitchell JM. Breast cancer treatment choice and mastectomy length of stay: a comparison of HMO and other privately insured women. Inquiry. 1997;34(4):288–301.PubMed
49.
Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr. 1995;18:41–7.
Metadata
Title
Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas
Authors
Pragati Advani
Melissa Bondy
Patricia A. Thompson
María Elena Martínez
Jesse N. Nodora
Sally W. Vernon
Pamela Diamond
Jason Burnett
Abenaa M. Brewster
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 5/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-018-0703-y

Other articles of this Issue 5/2018

Journal of Cancer Survivorship 5/2018 Go to the issue

Correction

Correction to: A systematic review of patient perspectives on surveillance after colorectal cancer treatment

OriginalPaper

Potential determinants of physical inactivity among long-term colorectal cancer survivors

OriginalPaper

Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016)

OriginalPaper

Factors influencing job loss and early retirement in working men with prostate cancer—findings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study

OriginalPaper

The relationship between physical impairments, quality of life and disability of the neck and upper limb in patients following neck dissection

OriginalPaper

Identifying barriers to cancer survivors sharing their survivorship care plans with their healthcare provider
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits